Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Joined February 2009
- Tweets 41,783
- Following 2,371
- Followers 151,063
- Likes 39,666
4,796 Photos and videos
At #ASCOBT26, learn how ctDNA and liquid biopsies are personalizing treatment for high-prevalence diseases like nasopharyngeal cancer in Asia Pacific. Register to join us online for livestreams and on-demand content.
Learn more: bit.ly/3Qsog0S
1
1
715
How is clinical AI transforming cancer care in Asia Pacific? Find out at #ASCOBT26. Learn about region-specific cancer care, multiomics, bedside AI tools, and more! Register to join us online for livestreams and on-demand content.
Learn more: bit.ly/3SHUvKf
9
9
1,393
ASCO retweeted
There’s still time to share your work and help shape the future of cancer care
Submit your abstract to the @ASCO #ASCOQLTY26 and join a community dedicated to advancing person-centered, high-quality oncology care
🗓️ Deadline: June 16, 11:59 PM ET
asco.confex.com/asco/qcs2026…
13
23
2,456
ASCO retweeted
Jun 14
I am very honoured to serve for one year term as a @ASCO International Affairs Committee and to participate in CEE Regional Council. Both roles are related to promoting global role of ASCO and my activities which I have been involved in for many years.
@NIO_PIB @OnkologiaPolska
1
1
21
2,227
Looking for a focused learning experience that allows you to quickly integrate the latest advances from #ASCO26? Register for an Officially Licensed Best of ASCO® --The only meetings officially authorized to deliver #ASCO26 content.
Find a city near you: bit.ly/3QEtB5r
1
1,024
Our LDP returns to the Asia Pacific region in 2027-28! 🌏 Expand your network, collaborate with regional peers, & build the skills needed to grow as a leader.
🗓️ Apply by August 17, 2026: bit.ly/4es4ege
8
7
1,706
Our new position statement outlines ways to expand eligibility, increase funding & expand community access for pediatric oncology clinical trials.
Learn more: bit.ly/4v1q7J7
#ASCOAdvocacy
1
7
22
2,136
Dr. @oncology_bg reflects on the meaningful impact the 2026 ASCO-AIOM International Clinical Research Course had on its attendees from across the globe.
Learn more: bit.ly/4vAQN3s
#ASCOConnection
4
12
1,766
The treatment landscape for EGFR-mutant NSCLC has entered an exciting but complex era. For #ASCODailyNews, @guicorreiamd, @VamsiVelcheti, and Varun Elete discuss 3 valuable first-line approaches and the use of #ctDNA clearance to adapt therapy: bit.ly/43w4DYV
1
5
7
2,551
ASCO retweeted
Jun 10
🚀 Applications are NOW OPEN for the 2027-28 ASCO Leadership Development Program: Asia Pacific!
As an alumnus, this program was genuinely transformative — rigorous leadership training, deep regional networks, lasting friendships and trusted collaborations that continue today.
For mid-career oncology physicians across AP ready to grow: don’t miss this opportunity!
📅 Deadline: 17 Aug 2026 (11:59 PM ET)
🔗 Apply: asco.smapply.org/prog/2027-2…
Pass it on to colleagues who should apply!
#ASCO #LDP #AsiaPacific #OncologyLeadership @ASCO
2
7
13
2,336
There is a global surge in young-onset cancers, particularly within Asia Pacific. @KimmieNgMD is looking forward to #ASCOBT26 to discuss why understanding these epidemiologic trends is more urgent than ever.
Register today: bit.ly/4uneRps
5
14
2,094
👏Big news! The #SeniorsAct now has 290 cosponsors, a key milestone. Momentum is building for bipartisan reforms to #FixPriorAuth & improve pt care. Congress needs to act NOW. Tell Congress to pass the Seniors Act. bit.ly/4e1Yf1x
#ASCOAdvocacy
Jun 10
🚨NEWS: This week, my legislation, the "Improving Seniors' Timely Access to Care Act," reached 290 co-sponsors in the U.S. House -- an overwhelming bipartisan supermajority.
This legislation puts patient care and patient outcomes first, and it will greatly modernize and streamline the prior authorization process.
Learn more⬇️
kelly.house.gov/media/press-…
1
9
19
3,838
Thank you @SenHydeSmith for your Senate floor speech on the harms of prior auth. We appreciate your support of the ASCO-endorsed Seniors’ Act and Safe Step Act to reduce utilization management burdens to get care to patients faster. #FixPriorAuth #ASCOAdvocacy
Patients across the country are waiting days, weeks, or even months for care their doctor already prescribed. And too often, it’s still denied.
Today, I urged the Senate to pass bipartisan legislation to stop insurance companies from standing between patients and the care they need.
More details: hydesmith.senate.gov/hyde-sm…
4
5
24
3,058
Researching pediatric brain tumors? There's still time to apply for the @conquercancerFD Young Investigator Award. One year. $50k. Mentored research.
Learn more and apply by July 15: bit.ly/4ohzrWL
#CancerResearch
3
11
2,253
Propel your career forward by submitting your research on topics ranging from Cost, Value & Policy to Tech. Innovation in Quality Care to #ASCOQLTY26 in Boston. Let’s advance quality cancer care together. Submit an abstract by June 16 at 11:59 PM (ET): bit.ly/3SakHgn
10
11
2,516
#ASCOAdvocacy thanks the House Appropriations Committee for prioritizing cancer research as it considers the FY27 LHHS spending bill & urges robust funding to keep pace with scientific discovery & fully support the nation's research infrastructure. More: bit.ly/3SvBVVy
6
15
1,693
The draft living guideline protocol for "Systemic Therapy and Biomarker Testing for HR-Positive, Non-HER2-Overexpressing Metastatic Breast Cancer" is now available. Help us refine these standards of care. Submit your feedback by June 22!
Learn more: bit.ly/4e4BmcA
10
10
2,448
ASCO retweeted
Excited to participate in @ASCO Leadership Dev Prog (LDP) and learn from this exceptional cohort of participants and mentors
1
2
11
2,740
ASCO Breakthrough has been gaining momentum since its inception in Thailand back in 2019. Hear from Dr. @TonyMok9 on how this vital conference has evolved and what's in store for #ASCOBT26 in Singapore.
Register today: bit.ly/3ROvRay
2
9
1,892
ICYMI at #ASCO26: GLP-1 RAs are associated with reduced metastatic progression of 4 different malignancies and improved OS in 7 tumor types, per the results of a real-world analysis of 10,000 patients with cancer. #ASCODailyNews has more: bit.ly/43dQ3VK
3
7
11
2,491